The effects of probiotic bacteria on glycaemic control in overweight men and women: a randomised controlled trial. (Q51326452)

3 April 2018

title

The effects of probiotic bacteria on glycaemic control in overweight men and women: a randomised controlled trial. (English)

1 reference

3 April 2018

0 references

0 references

K L Ivey

1

1 reference

3 April 2018

J M Hodgson

2

1 reference

3 April 2018

D A Kerr

3

1 reference

3 April 2018

J R Lewis

4

1 reference

3 April 2018

P L Thompson

5

1 reference

3 April 2018

R L Prince

6

1 reference

3 April 2018

publication date

26 February 2014

1 reference

3 April 2018

European Journal of Clinical Nutrition

published in

1 reference

3 April 2018

volume

68

1 reference

3 April 2018

issue

4

1 reference

3 April 2018

page(s)

447-452

1 reference

3 April 2018

https://scigraph.springernature.com/pub.10.1038/ejcn.2013.294

exact match

0 references

cites work

Development of retinopathy and proteinuria in relation to plasma-glucose concentrations in Pima Indians.

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2013.294

Epidemiological evidence for the association of hyperglycaemia and atherosclerotic vascular disease in non-insulin-dependent diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2013.294

Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2013.294

High blood glucose concentration is a risk factor for mortality in middle-aged nondiabetic men. 20-year follow-up in the Whitehall Study, the Paris Prospective Study, and the Helsinki Policemen Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2013.294

The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2013.294

Oxidative stress, insulin signaling, and diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2013.294

The global diabetes epidemic as a consequence of lifestyle-induced low-grade inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2013.294

Host-bacterial mutualism in the human intestine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2013.294

Gut microbiota in human adults with type 2 diabetes differs from non-diabetic adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2013.294

Differential adaptation of human gut microbiota to bariatric surgery-induced weight loss: links with metabolic and low-grade inflammation markers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2013.294

High-fat diet: bacteria interactions promote intestinal inflammation which precedes and correlates with obesity and insulin resistance in mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2013.294

Metabolic syndrome and altered gut microbiota in mice lacking Toll-like receptor 5

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2013.294

An obesity-associated gut microbiome with increased capacity for energy harvest

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2013.294

The gut microbiota as an environmental factor that regulates fat storage

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2013.294

The improvement of hypertension by probiotics: effects on cholesterol, diabetes, renin, and phytoestrogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2013.294

Effects of a milk product, fermented by Lactobacillus acidophilus and with fructo-oligosaccharides added, on blood lipids in male volunteers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2013.294

Cholesterol-lowering effect of probiotic yogurt in comparison with ordinary yogurt in mildly to moderately hypercholesterolemic subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2013.294

Probiotics and dietary counselling contribute to glucose regulation during and after pregnancy: a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2013.294

Antidiabetic effect of probiotic dahi containing Lactobacillus acidophilus and Lactobacillus casei in high fructose fed rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2013.294

Antidiabetic effect of Lactobacillus GG in streptozotocin-induced diabetic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2013.294

Probiotics for the prevention of beta cell autoimmunity in children at genetic risk of type 1 diabetes--the PRODIA study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2013.294

Probiotic Lactobacillus reuteri promotes TNF-induced apoptosis in human myeloid leukemia-derived cells by modulation of NF-kappaB and MAPK signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2013.294

Oral probiotic administration induces interleukin-10 production and prevents spontaneous autoimmune diabetes in the non-obese diabetic mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2013.294

Probiotics-host communication: Modulation of signaling pathways in the intestine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2013.294

International physical activity questionnaire: 12-country reliability and validity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2013.294

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2013.294

Design, analysis and presentation of factorial randomised controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2013.294

Decrease in fibrinogen and LDL-cholesterol levels upon supplementation of diet with Lactobacillus plantarum in subjects with moderately elevated cholesterol.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2013.294

Different effects of whole milk and a fermented milk with the same fat and lactose content on gastric emptying and postprandial lipaemia, but not on glycaemic response and appetite

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2013.294

Impact of Bifidobacterium animalis subsp. lactis BB-12 and, Lactobacillus acidophilus LA-5-containing yoghurt, on fecal bacterial counts of healthy adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2013.294

Genomic and metabolic studies of the impact of probiotics on a model gut symbiont and host

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2013.294

Understanding the effects of diet on bacterial metabolism in the large intestine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2013.294

Adaptations of glucose metabolism during pregnancy and lactation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2013.294

Partitioning of nutrients during pregnancy and lactation: a review of mechanisms involving homeostasis and homeorhesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2013.294

Removal of cholesterol by lactobacilli via incorporation and conversion to coprostanol

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2013.294

Effect of a probiotic formula on intestinal immunoglobulin A production in healthy children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2013.294

Influence of intestinal microbes on heat production in germ-free, gnotobiotic and conventional mice

21 January 2018

1 reference

12 December 2020

Protection from gastrointestinal diseases with the use of probiotics

1 reference

12 December 2020

Protection mechanism of probiotic combination against human pathogens: in vitro adhesion to human intestinal mucus

1 reference

12 December 2020

Development of the Melbourne FFQ: a food frequency questionnaire for use in an Australian prospective study involving an ethnically diverse cohort

1 reference

12 December 2020

Carbohydrate and lipid metabolism during normal pregnancy: relationship to gestational hormone action

1 reference

12 December 2020

Hypocholesterolaemic effect of a new fermented milk product in healthy middle-aged men.

1 reference

12 December 2020

NIDDM and its metabolic control predict coronary heart disease in elderly subjects

1 reference

12 December 2020

Effects of the probiotic strain Lactobacillus johnsonii strain La1 on autonomic nerves and blood glucose in rats

1 reference

12 December 2020

The Anti Cancer Council of Victoria FFQ: relative validity of nutrient intakes compared with weighed food records in young to middle-aged women in a study of iron supplementation

1 reference

12 December 2020

Antidiabetic effects of an oral administration of Lactobacillus casei in a non-insulin-dependent diabetes mellitus (NIDDM) model using KK-Ay mice

1 reference

12 December 2020

Effect of Lactobacillus plantarum 299v on cardiovascular disease risk factors in smokers

1 reference

12 December 2020

Metabiotics: novel idea or natural development of probiotic conception

1 reference

12 December 2020

International Diabetes Federation: a consensus on Type 2 diabetes prevention

1 reference

12 December 2020

Evaluation of the effects of a new fermented milk product (Gaio) on primary hypercholesterolemia

1 reference

12 December 2020

International table of glycemic index and glycemic load values: 2002.

1 reference

12 December 2020

Effect of galacto-oligosaccharide supplementation on human faecal microflora and on survival and persistence of Bifidobacterium lactis Bb-12 in the gastrointestinal tract

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2013.294

7 January 2021

inferred from DOI database lookup

Identifiers

DOI

10.1038/EJCN.2013.294

1 reference

3 April 2018

PubMed ID

24569536

1 reference

3 April 2018